A new study models the impact of 4 key public health interventions on global HCV burden to see if WHO elimination targets are realistic.
Direct Mail to Older Adults at Risk for Pneumococcal Disease Improves Vaccination Rates
A mail campaign targeting adults with chronic conditions as well as their GPs increased the number receiving at least 1 shot by 9.5 percentage points.
Primary Viewpoints: Immunizations with Dr Steven P. Furr
"Primary Viewpoints," a podcast from Patient Care Online, brings you an exclusive interview with Steven P. Furr, former president of the American Academy of Family Physicians.
FDA Authorizes Marketing of First At-Home Test for Chlamydia, Gonorrhea, Trichomoniasis
The Women’s Sexual Health Test (Visby Medical) delivers results in approximately 30 minutes using a vaginal swab.
Respiratory Tripledemic 2022-23: An Expert Recap
William Schaffner, MD, medical director of the NFID, provides an expert recap of the 2022-2023 respiratory virus season for primary care clinicians.
Sanofi's Chlamydia Vaccine Granted FDA Fast Track Designation
The FDA granted fast track designation to Sanofi’s chlamydia vaccine candidate today, aiming to prevent infections and address an unmet public health need.
FDA Approves Gepotidacin (Blujepa) for Treatment of Uncomplicated UTIs
Gepotidacin is the first new oral antibiotic for uncomplicated urinary tract infections in 30 years, offering an alternative amid rising antibiotic resistance.